𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A 3 mg/kg starting dose of infliximab in active spondyloarthritis resistant to conventional treatments is efficient, safe and lowers costs

✍ Scribed by Ginette Tenga; Vincent Goëb; Thierry Lequerré; Hélène Bacquet-Deschryver; Alain Daragon; Sophie Pouplin; Karine Lanfant-Weybel; Xavier Le Loët; Bernard Dieu; Olivier Vittecoq


Book ID
113684902
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
178 KB
Volume
78
Category
Article
ISSN
1297-319X

No coin nor oath required. For personal study only.